- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 277/00 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
Patent holdings for IPC class C07D 277/00
Total number of patents in this class: 98
10-year publication summary
|
7
|
7
|
2
|
2
|
2
|
3
|
1
|
2
|
2
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Vertex Pharmaceuticals Incorporated | 1600 |
5 |
| Case Western Reserve University | 1825 |
4 |
| Amgen Inc. | 4076 |
3 |
| Syngenta Participations AG | 1904 |
2 |
| Allergan, Inc. | 2347 |
2 |
| Bayer Cropscience AG | 2040 |
2 |
| The Trustees of the University of Pennsylvania | 4323 |
2 |
| CARA Therapeutics, Inc. | 49 |
2 |
| FerroKin Biosciences, Inc. | 5 |
2 |
| Synapse Biosciences, LLC | 4 |
2 |
| Compagnie Generale des Etablissements Michelin | 4746 |
2 |
| Corteva Agriscience LLC | 2682 |
2 |
| Bristol-myers Squibb Company | 4880 |
1 |
| F. Hoffmann-La Roche AG | 7947 |
1 |
| Sandoz AG | 1417 |
1 |
| The Regents of the University of California | 19961 |
1 |
| Merck Sharp & Dohme Corp. | 2191 |
1 |
| E. I. du Pont de Nemours and Company | 4050 |
1 |
| Bayer AG | 3325 |
1 |
| Sumitomo Chemical Company, Limited | 9043 |
1 |
| Other owners | 60 |